🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsTRIUMPH program trial design overview — all Phase 3 arms Page 15

TRIUMPH program trial design overview — all Phase 3 arms

TrialTracker_MD Mon, Feb 26, 2024 at 4:00 PM 324 replies 45,778 viewsPage 15 of 20
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Sep 3, 2024 at 3:23 PM#71
Dr.PulmRoch said:
Start from the measurement rather than the conclusion.

Adding the part of the answer the thread has not reached. Take it one variable at a time. Almost every unanswerable question in these threads is unanswerable because three things changed in the same fortnight, and no amount of subsequent argument can untangle them after the fact.

46 21Dr.LipidDallas, alex_tucson, kevin_tulsa and 43 others
Reply Quote Save Share Report
Dr.PathRoch
Member
456
2,123
Jun 2024
Rochester, MN
Sep 7, 2024 at 2:02 AM#72

One concrete data point for the thread. Keep the original post as written when you update it, and add the correction underneath. An edited-away mistake is invisible to the next person who makes it.

45 20InsuranceTom, WendyG_ATL, SaraMom3 and 42 others
Reply Quote Save Share Report
laura_annarbor
Member
189
890
Dec 2024
Ann Arbor, MI
Sep 10, 2024 at 12:39 PM#73

One thing that is still open after Dr.PulmRoch’s answer:

Was that from a primary source or from a summary of one?

44 19Dr.SleepRoch, laura_annarbor, JenMemphis and 41 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
VendorMark
Senior Member
3,456
14,567
Jan 2024
Texas
Online
Sep 13, 2024 at 11:14 PM#74
Dr.PathRoch said:
Keep the original post as written when you update it, and add the correction underneath.

This is where I part company with the consensus forming above. Not convinced. The evidence being cited is consistent with the conclusion and also consistent with two other conclusions nobody has ruled out.

Last edited: Sep 14, 2024 at 1:14 AM
43 18Dr.PeteFamMed, claudia_zurich, nancy_portland and 40 others
Reply Quote Save Share Report
denise_HTX
Member
145
678
Jan 2025
Houston, TX
Sep 17, 2024 at 9:47 AM#75
Dr.PathRoch said:
Keep the original post as written when you update it, and add the correction underneath.

Agreed, with the usual condition: that holds for the average and this board is a collection of individuals. A population claim and a personal prediction are different things and get quoted interchangeably.

Last edited: Sep 17, 2024 at 11:47 AM
42 17TirzTom, TrialTracker_MD, JennaRN and 39 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register